Welcome To Market And Economic Re-education Camp

 | Feb 28, 2020 04:11PM ET

For the casual observer, the stock market’s rapid slide looks like madness. It was, after all, only last week that the S&P 500 closed at a record high. Six trading days later, the market had lost 12% (as of Feb. 27) – the fastest correction on record for declines of 10%-plus. But before we let recency bias take complete control of our minds, let’s consider if there’s a method in Mr. Market’s madness.

At its core, the sharp decline in stock prices is an effort to reprice a future that must deal with the coronavirus (Covid-19) on the world stage. It now appears that containing the virus is impossible. The World Health Organization says the Covid-19 outbreak has reached a “decisive point” and has “pandemic potential.” The outlook as recently as a week ago, when the S&P traded at a record high, is ancient history.

The operative question for the market’s sharp refocus is neatly summed up by the famous line attributed to John Maynard Keynes: “When the facts change, I change my mind. What do you do, sir?”

Mr. Market emphatically chooses the latter, as he always does. In the short run, discounting the future can be a messy business, as recent days remind. More of the same is likely coming. The basic issue here is that a Covid-19-laced future is considerably more uncertain compared with the pre-coronavirus outlook. The transition is all the tougher because the U.S. stock market had, for weeks, effectively ignored coronavirus risk, preferring instead to price in smooth economic sailing and discounting an unusually sunny future. And then suddenly, Mr. Market thought otherwise and the results are ugly as sentiment tries to play catch-up with world events.

It’s not unlike a traveler who was expecting a mild, spring day and instead finds himself in the middle of a hurricane. Shifting to reality is destined to be challenging in the best of circumstances and is made all the worse because he’s dressed for beach weather. Result: attitude adjustment on steroids, in record time.

The market, in short, is being forced to discount a future with little if any context in modern times. It’s reasonable to assume that Covid-19 will continue to spread. Meanwhile, a vaccine is probably months away. Uncertainty has spiked and so the market demands a bigger discounting factor – a bigger margin of comfort until there’s more confidence for understanding what’s unfolding.

No one’s certain how this will play out and so the market is prudently erring on the side of caution. But this is hardly the first time that the crowd has been faced an impossible task of pricing in a future with new and materially bigger risks with unclear outcomes.

Get The News You Want
Read market moving news with a personalized feed of stocks you care about.
Get The App

From an investor’s perspective, it’s all deeply unsettling, of course. As painful as a correction is, it’s helpful to keep in mind that we’ve been here before from a pricing perspective. The current 12% drawdown for S&P (as of Feb. 2) is, for now, a middling peak-to-trough decline vs. the market history since 1960.